Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001588968-19-000005
Filing Date
2019-03-13
Accepted
2019-03-13 17:39:08
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2986
  Complete submission text file 0001588968-19-000005.txt   4474
Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 312-283-5793
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address
Kumar Hari (Reporting) CIK: 0001588968 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55292 | Film No.: 19679137